Value of mammography and combined grey scale ultrasound and ultrasound elastography in the differentiation of solid breast lesions  by Mohey, Nesreen & Hassan, Tamir A.
The Egyptian Journal of Radiology and Nuclear Medicine (2014) 45, 253–261Egyptian Society of Radiology and Nuclear Medicine
The Egyptian Journal of Radiology andNuclearMedicine
www.elsevier.com/locate/ejrnm
www.sciencedirect.comREVIEWValue of mammography and combined grey
scale ultrasound and ultrasound elastography
in the diﬀerentiation of solid breast lesions* Corresponding author. Tel.: +20 1001952536.
E-mail address: tamirhaq@yahoo.com (T.A. Hassan).
Peer review under responsibility of Egyptian Society of Radiology and
Nuclear Medicine.
Production and hosting by Elsevier
0378-603X  2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear Medicine.
http://dx.doi.org/10.1016/j.ejrnm.2013.11.002Open access under CC BY-NC-ND license.Nesreen Mohey, Tamir A. Hassan *Radiodiagnosis Department, Faculty of Medicine, Zagazig University, EgyptReceived 6 November 2013; accepted 11 November 2013





UEAbstract Aim of the work: The aim of this work was to evaluate the value of ultrasound
elastography (UE) in differentiating benign versus malignant solid breast lesions discovered in
mammography and compare it with grey scale ultrasound (US) and mammography.
Methods: From May 2011 to May 2013, 114 solid lesions from 100 consecutive patients discovered
during mammography were categorized into benign or malignant by mammography and US and
further analyzed with UE. The diagnostic results of the cases were compared with histopathologic
ﬁndings.
Results: Of 114 lesions, 33 were histologically malignant, and 81 were benign. UE was the most
speciﬁc (95.1%) of the 3 modalities. The accuracy (81.7%) of UE was equal to mammography
and was higher than those of US (82.5% and 71.9%, respectively). A combination of UE and
US had the best sensitivity (90.9%) and accuracy (93.8%).
Conclusions: Ultrasound elastography is useful for breast lesion characterization and is an easier
and cheaper method and more speciﬁc than mammography or US alone, but it is operator
dependent. When combined with US, detection accuracy can be greatly improved and the
combination potentially could reduce unnecessary biopsy.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.
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Breast cancer is the most common malignancy in women and
the second most common cause of cancer-related mortality (1).
Most breast masses are benign (2). Breast masses have a vari-
ety of etiologies, benign and malignant. Fibroadenoma is the
most common benign breast mass; invasive ductal carcinoma
is the most common malignancy (3). Ultrasonography can
effectively distinguish solid masses from cysts, which account
for approximately 25% of breast lesions. Also it differentiates
benign from malignant lesions if their criteria of diagnosis are
fulﬁlled (4).
Sonoelastography is an imaging modality that can quanti-
tatively measure tissue elasticity with the use of sonography
(5). Several clinical studies showed that sonoelastography
was useful for differentiation benign and malignant breastFig. 1 Elasticity scores, quolesions, with a sensitivity of 78.0–100% and a speciﬁcity of
91.0–98.5%. A discrepancy in lesion sizes between the use of
B-mode sonography and sonoelastography in comparison with
gold standard pathology dimensions was a key factor for the
diagnostic criteria in several studies as the UE measurements
were more similar to the gold standard pathology dimensions
than B-mode alone (6–8). Real-time tissue elastography may
provide additional characterization of breast lesions, improv-
ing speciﬁcity, particularly for low-suspicion lesions (9).
Ultrasound elastography is a new imaging mode that dis-
plays tissue softness or hardness in real time as a colour map
that translucently overlays the conventional B-mode image.
Because malignant tumors predominantly are harder than
benign tissues, this technique signiﬁcantly improves the differ-
entiation between benign and malignant tissues. Itoh et al. (11)
reported a good correlation between real-time ultrasound elas-ted from Itoh et al. (11).
Fig. 2 Forty-nine year-old female right breast invasive ductal carcinoma. (A) and (B) Diagnostic mammogram ‘‘MLO and compression
views’’ reveal heterogeneously dense breast with dense mass showing irregular borders (triangular mark over the palpable mass). (C) US
(left) and UE (right) reveal irregular outline hypoechoic lesion, and UE shows score 5.
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speciﬁcity for classifying benign versus malignant masses (10).
2. Patients and methods
This study was done during the period from May 2011 to May
2013 in JCI (Joint Commission International) accredited hos-
pital in Saudi Arabia, where screening mammogram is
routinely done. We selected 114 solid lesions from 100 consec-
utive patients, either complaining of breast lump or during
their screening mammogram with exclusion of cystic lesions.
Mean age was 44.2 years. Approval of the medical ethics com-
mittee was obtained and all patients gave their informed con-
sent prior to the study.2.1. Mammography
Mammography was performed using analogue machine
(Planmed Nuance Classic, Shimadzu medical systems, Austral-
asia) or digital machine (Hologic–Selenia Dimensions 2D full
ﬁeld digital mammography). Images are reviewed on a dedi-
cated work station, ACR (American colleague of Radiology)
approved for mammography reading (Barko screens, 5 mega-
pixels dedicated for mammography). We ensure that the lights
are off during review. Mammography was done either as diag-
nostic for patients with lump in breasts (45 patients with 45 le-
sions) or as screening mammography according to inclusion
and exclusion criteria for screening as follows (55 patients with
69 lesions).
Fig. 3 Forty-two year-old female with left breast invasive ductal carcinoma. (A) and (B) Screening mammogram ‘‘MLO and
compression views’’ reveal heterogeneously dense breast coarse macro-calciﬁcations as well as dense mass showing irregular borders. (C)
US (left) and UE (right) reveal irregular outline hypoechoic lesion, and UE shows score 4.
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1. Females between 40 and 70 years of age.
2. Females with a positive family history in the ﬁrst degree rel-
ative will have their screening 5 years earlier than the age of
the breast cancer had been discovered in the relative.2.1.2. Exclusion criteria for screening mammogram
1. Pregnancy.
2. Lactation; the exam will be postponed till 6 months after
cessation of lactation.
3. Painful breast conditions.
Standard mediolateral oblique (MLO) and craniocaudal
(CC) projections were obtained. Additional projections, such
as coned-down compression and magniﬁcation views, were
considered when further help in analysis was expected.
Mammograms were reviewed for masses, calciﬁcations,architectural distortion, and tubular ductal opacity. The shape,
margin, and density of masses were noted. Two different radi-
ologists with at least 5 years of experience in breast mammog-
raphy read the mammograms and made the diagnosis of the
lesions together.
2.2. Breast grey scale US and US elastography
Breast US and US elastography were performed using a real
time ultrasound (GE LOGIQ P6, using linear high frequency
probe with frequency of 10 MHz, GE Medical Systems,
USA). They were done to all selected patients with solid breast
lesions discovered in screening mammogram, US features were
prospectively recorded and included anteroposterior-width ra-
tio, shape, margin, internal echogenicity (hypoechoic or iso-
echoic; compared with the subcutaneous fat), internal echo
texture, and posterior acoustic phenomena. Cystic lesions were
excluded. With these features, the lesions were classiﬁed as be-
nign or malignant.
Fig. 4 Forty year-old female with multiple bilateral ﬁbroadenomas. (A) and (B) Screening mammography ‘‘MLO’’ reveals extremely
dense breasts that reduces sensitivity of mammography. (C) UE reveals well deﬁned right breast mass with score 1. (D) UE reveals well
deﬁned left breast mass with score 2.
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same machine and the same probe. The probe was placed on
the breast with light pressure, and a box was highlighted by
the operator that included the nodule to be evaluated. In the
case of multiple nodules, each nodule is evaluated separately.
The principle of US elastography is to acquire two ultrasonic
images (before and after tissue compression by the probe)
and track tissue displacement by assessing the propagation
of the imaging beam. A scale is available on the machine to
measure if adequate compression was used. The US elasto-
gram was displayed over the B-mode image in a colour scale
that ranges from red, for components with the greatest elastic
strain (i.e. softest components), to blue for those with no strain
(i.e. hardest components). The elastograms were thus obtained
and we assigned each image an elasticity score on a ﬁve-point
scale. A score of 1 indicated even strain for the entire hypoech-
oic lesion (i.e., the entire lesion was evenly shaded in green). A
score of 2 indicated strain in most of the hypoechoic lesion,
with some areas of no strain (i.e., the hypoechoic lesion hada mosaic pattern of green and blue). A score of 3 indicated
strain at the periphery of the hypoechoic lesion, with sparing
of the centre of the lesion (i.e., the peripheral part of lesion
was green, and the central part was blue). A score of 4 indi-
cated no strain in the entire hypoechoic lesion (i.e., the entire
lesion was blue, but its surrounding area was not included).
A score of 5 indicated no strain in the entire hypoechoic lesion
or in the surrounding area (i.e., both the entire hypoechoic le-
sion and its surrounding area were blue) ((11), Fig. 1). It is
important that the level of pressure is maintained constant
throughout the examination.
All examinations were performed by the same radiologist,
who reviews the mammogram. Static and moving images were
also recorded to be reviewed subsequently by the second radi-
ologist. The agreement on the scoring of US parameter was
93.9% between the two radiologists. In particular, scoring by
the two examiners was coincident in 107 of the 114 lesions.
In 7 lesions the ﬁnal score was agreed after conjoint re-exam-
ination of the recorded movies.
Fig. 5 Forty-one year-old female with intraductal papilloma. (A) and (B) Screening mammogram ‘‘MLO and CC views’’ reveal few
scattered ﬁbroglandular densities with well deﬁned nodule showing regular borders at the right breast. (C) US reveals duct ectasia with
well deﬁned intraductal echogenic lesion (arrow heads). (D) UE reveals score 3.
258 N. Mohey, T.A. Hassan3. Results
This study included 100 patients with 114 solid breast lesions.
All the solid breast lesions were diagnosed histologically by
means of radical surgery, excisional biopsy, or needle biopsy.
The pathologic results were correlated with the US and UE
ﬁndings.
Histologic analysis showed that 81 (71.1%) of 114 lesions
were benign (Figs. 4–6) and 33 (28.9%) of 114 lesions were
malignant (Figs. 2 and 3). The histologic diagnoses are
summarized in Table 1. Lesion sizes ranged from 4 to
90 mm in maximum diameter (mean, 13.2 mm); in particular,
the benign lesions were 4–90 mm (mean, 13 mm), and the
malignant lesions were 5.2–48 mm (mean, 21 mm). The
sensitivity of mammography (72.7%) alone was higher than
US (69.7%) or US elastography (69.7%) (Table 2). The
speciﬁcity of UE (95.1%) was signiﬁcantly higher than those
of mammography (86.4%) and US (72.8%). The accuracy
rates of mammography (82.5%) and UE (81.7%) were sig-
niﬁcantly higher than that of US (71.9%). Combined UE
and US had the best results for detection of cancer (sensitiv-
ity 90.9%, speciﬁcity 95.1% and accuracy 93.8%, P-value
0.0001) (Table 2). On US elastography: score 1 was foundin 20 cases, all benign lesions; score 2 in 52 cases, one of
them was malignant; score 3 in 14 cases, 5 benign and 9 car-
cinoma; score 4 in 17 cases, 4 benign and 13 carcinomas and
score 5 in 10 cases; all carcinomas (Table 3). Thus, 72 of the
81 cases with a ﬁnal diagnosis of benign lesion had a score
of 1–2 (88.9%) and 23 of 33 (69.7.1%) with a ﬁnal diagnosis
of carcinoma had a score of 4–5 (Table 3).
Mammographic ﬁndings were false-negative in 9 of 33 can-
cers; US and UE ﬁndings were false-negative in 10 of 33 can-
cers (Table 2). With regard to the false-negative rate, no
signiﬁcant difference between the 3 modalities was found.
Most false negative ﬁndings on UE were found in early stages
of invasive ductal carcinoma, which were all in stages 1 and 2,
and noninvasive carcinoma. When the diagnoses from UE and
US were combined, the false-negative rate was 30 of 33 can-
cers, which was signiﬁcantly lower than that of any of the three
modalities alone.
4. Discussion
Breast cancer is the most common malignancy among women
worldwide. In the absence of a known preventable cause of
breast cancer, the single most important factor in reducing
Fig. 6 Fifty-one year-old female with large left breast ﬁbroadenoma. (A) and (B) Diagnostic mammogram ‘‘CC and MLO views’’ reveal
few scattered ﬁbroglandular densities with coarse macro-calciﬁcations as well as well deﬁned left breast retro-areolar mass. (C) US (left)
and UE (right) reveal well deﬁned hypoechoic mass, with UE score 2.
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is early detection through screening (13).
From a diagnostic point of view, Itoh et al. (11) ﬁndings
concur with those of other studies – namely, that elastography
is useful for characterizing breast lesions in general and has the
potential to allow differentiation between malignant and be-
nign lesions (11–13).
In our study, no malignant lesions had a score 1 in
agreement with (11,12) studies; they believed that an elastic-
ity score 1, which shows even strain in the entire hypoechoic
lesion at B-mode US, indicates that lesions have almost thesame compressibility as the surrounding breast tissue, this
result suggests that invasive diagnostic procedures, such as
ﬁne needle aspiration, may be avoided for patients who have
lesions with a score 1.
In our study 52 cases of ﬁbroadenomas had elasticity scores
2 in agreement with (11) who mentioned that ﬁbroadenomas
are hypoechoic lesion and are soft at EU yet somewhat harder
than normal breast tissue which is often characteristic of le-
sions such as ﬁbroadenoma or ANDI (abbreviations in the
normal development and involution of the breast) which is
the term describing most of benign breast diseases (11).
Table 1 Histopathological diagnosis of 114 solid breast
lesions.
Histopathological diagnosis Number





Malignant lesions (n = 33)
Invasive ductal carcinoma 26
Ductal carcinoma in situ 3
Cystosarcoma phyllodes 1
Medullary carcinoma 1
Invasive lobular carcinoma 1
Papillocarcinoma 1
Table 3 Distribution of elasticity scores in the 114 solid breast
lesions.
Elasticity score Benign (n= 81) Malignant (n= 33)
Score 1 20 –
Score 2 52 1
Score 3 5 9
Score 4 4 13
Score 5 – 10
Score 1–2 72 1
Score 4–5 4 23
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score (ES) of 4–5, whereas 76% of benign lesions had an ES of
1–2. In (12) study no malignant lesions show elastography
score 1, 72% of benign lesions showed elastography score
1–2 and 84% of malignant lesions present elastography score
4–5. In our study no malignant lesions show elastography
score 1, 88.9% of the benign lesion had a score of 1–2 and
69.7.1% of the malignant lesions had a score of 4–5 which is
near to previous studies.
In our study 9 cases out of the 14 cases (64.3%) showing
elasticity score 3 were malignant in agreement with (12). Itoh
et al., (11) concluded that elasticity score 3 requires further
investigation, e.g. aspiration cytology or needle biopsy.
The sensitivity and speciﬁcity of elastography were 83.3%,
86.7% in (11) study, and in (12) study, the sensitivity and spec-
iﬁcity of elastography were both 84%. In (13) study sensitivity,
speciﬁcity; and accuracy were 89.7%, 95.7% and 93.9%. In
our study sensitivity, speciﬁcity, and accuracy were 69.7%,
95.1% and 81.7% which are in agreement with the previously
mentioned results.
In our study the sensitivity of mammography (72.7%) alone
was higher than US (69.7%) or US elastography (69.7%) in
agreement with (13). The speciﬁcity of UE (95.1%) was higher
than those of mammography (86.4%) and US (72.8%). Com-
bined UE and US had the best results for detection of cancer
(sensitivity 90.9%, speciﬁcity 95.1% and accuracy 93.8%) in
agreement with (13).
In our study no signiﬁcant difference between the 3 modal-
ities was found with regard to the false-negative rate. Most
false negative ﬁndings on UE were found in early stages of
invasive ductal carcinoma and noninvasive carcinoma. WhenTable 2 Sensitivity, speciﬁcity and accuracy of the mammography, U
malignant breast lesions.
Imaging modality Sensitivity (%) (n) Spec
Mammography 72.7 (24/33) 86.4
US 69.7 (23/33) 72.8
UE 69.7 (23/33) 95.1
Combined US + UE 90.9 (30/33) 95.1
** P> 0.05 not signiﬁcant, P< 0.05 signiﬁcant, P< 0.01 highly signiﬁcthe diagnoses from UE and US were combined, the false-neg-
ative rate was 30 of 33 cancers, which was signiﬁcantly lower
than that of any of the three modalities alone in agreement
with (13).5. Conclusion
Ultrasound elastography is useful for breast lesion character-
ization and is an easier, cheaper method and more speciﬁc than
mammography or US alone, but it is operator dependent.
When combined with US, detection accuracy can be greatly
improved and the combination potentially could reduce unnec-
essary biopsy especially for elasticity score 1–2.
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